PhotoDetection Systems'
NeuroPET scanner
Boxboro, MA -- PhotoDetection Systems (PDS) has introduced its high-sensitivity NeuroPET scanner, which was featured in an oral presentation to the SNM molecular imaging community.
Accepted scientific abstracts including NeuroPET data and images were presented by PDS and our collaborators at Massachusetts General Hospital during the Society of Nuclear Medicine's (SNM) annual meeting held June 13-16, 2009. In addition, NeuroPET product information and image quality demonstrations were well received at our exhibit booth.
The NeuroPET has been designed to serve the clinical and research needs of the molecular neuro-imaging community, and it has recently received FDA 510(k) clearance. NeuroPET's state-of-the-art, patented wavelength-shifting fiber technology enables ultra high-sensitivity and excellent spatial resolution. Its compact/portable design requires no special site preparation and allows for significantly reduced cost of ownership compared to general-purpose PET scanners. NeuroPET uses very low doses of 18F and 11C tracers to image metabolism, amyloid, and dopaminergic binding in neurological diseases. These tracers are known to be helpful in imaging challenging and costly diseases such as Alzheimer's, Neuro-oncology, Epilepsy, Parkinson's and Neuro-psychiatric disorders. NeuroPET can complement existing clinical and research efforts with high quality, low cost neuro-imaging capacity and its ultra high-sensitivity performance can allow for more frequent repeat low dose scanning of the same subject to monitor response to therapy.
"Our strong development team is fortunate to be working with excellent collaborators and we are very enthusiastic about the NeuroPET's measured capabilities, its accessible utility, and the positive reception we have received at the SNM meeting," stated Bill Worstell, PhD, PDS Chief Technology Officer.
About PhotoDetection Systems
Founded at Boston University's Photonic Center in 1999, PhotoDetection Systems (PDS) is committed to delivering the highest quality PET imaging at the lowest dose for research and clinic use. Our growing team works in an ISO 13485-certified facility with R&D, Operations and Customer Support Services in place. The PDS mission is to provide PET imaging technologies to the research and clinical communities that may enable development of effective treatments, monitoring, and early detection of disease. Visit www.photodetection.com.
